The Netherlands grants permit to build nuclear reactor for first time in decades; it will produce radiopharmaceuticals

The Dutch Authority for Nuclear Safety and Radiation Protection (ANVS) has issued a construction permit for the Pallas research reactor in Petten, the Netherlands. The new facility will replace the existing High Flux Reactor (HFR). Its main purpose will be to produce radiopharmaceuticals.
The application to build and operate the Pallas facility was submitted in June 2022. It included an environmental impact assessment (EIA) and a reactor safety report. The EIA documents systematically and objectively describe all the environmental impacts of operating the reactor and the entire facility. The safety report describes many other aspects, including how the facility operates, from the design and operation of cooling pipes and ventilation systems to accident conditions and how they are managed.
The company responsible for obtaining the construction permit, finding private investors, and building and operating the entire plant also applied to Rijkswaterstaat (RWS) for a permit under the Water Act to draw cooling water from the North Holland Canal and discharge water into the North Sea.
Translation disclaimer
This article is a machine translation of the Czech original and has not yet been fully reviewed. In case of any doubt, please refer to the Czech version.
The article continues for subscribers
Premium content
The rest of this article is available to premium subscribers only. Get access to all premium articles on oEnergetice.cz.
You have read only 30% of the article — unlock the remaining 70% with a premium subscription.
Best value: annual subscription
Monthly option 4 € / month
3.25 €/ month




